The Ruminant Vaccines Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of ruminant vaccines has seen significant growth in the past few years. It is projected to increase from $2.98 billion in 2024 to $3.19 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.9%.
The Ruminant Vaccines Global Market Report 2025 forecasts that by 2029, the market size for ruminant vaccines will be approximately $4.13 billion, growing at a compound annual growth rate (CAGR) of 6.7%.
Download Your Free Sample of the 2025 Ruminant Vaccines Market Report and Uncover Key Trends Now!The key drivers in the ruminant vaccines market are:
• Rising investments in research and development for ruminant vaccines
• Expansion and modernization of veterinary clinics and hospitals
• Increasing consumption of meat and dairy products
• Greater focus on preventive healthcare in animals and globalization of livestock trade
The ruminant vaccines market covered in this report is segmented –
1) By Vaccine Type: Inactivated Vaccines, Attenuated Or Modified Live Vaccines, Other Vaccine Types
2) By Indication: Bovine Respiratory Diseases (BRD), Diarrhea Or Scours, Foot-and-Mouth Disease (FMD), Clostridial Diseases, Leptospirosis, Bovine Viral Diarrhea (BVD) Infection, Other Indication
3) By Route Of Administration: Intramuscular, Subcutaneous, Intranasal, Oral
4) By Application: Cattle, Sheep, Other Applications
5) By End-User: Veterinary Hospitals And Clinics, Livestock Farms, Research Institutes
Subsegments:
1) By Inactivated Vaccines: Killed Virus Vaccines, Bacterial Inactivated Vaccines, Subunit Vaccines
2) By Attenuated or Modified Live Vaccines: Live Attenuated Virus Vaccines, Live Bacterial Vaccines, Recombinant Live Vaccines
3) By Other Vaccine Types: DNA Vaccines, mRNA Vaccines, Viral Vector Vaccines
The key trends in the ruminant vaccines market are:
• Adoption of recombinant and DNA vaccines is a key emerging trend.
• There is an increased focus on the innovation in autogenous vaccine usage.
• The development of thermostable vaccines is gaining traction.
• The integration of artificial intelligence in vaccine development and use of nanotechnology in vaccine delivery are notable trends.
Major players in the ruminant vaccines market are:
• Boehringer Ingelheim International GmbH
• Zoetis Inc.
• Merck & Co. Inc.
• Elanco Animal Health Inc.
• Ceva Santé Animale
• Virbac
• Phibro Animal Health Corporation
• Vetoquinol S.A.
• Indian Immunologicals Ltd.
• Anicon Labor GmbH (SAN Group)
• IDT Biologika GmbH
• Jinyu Bio-Technology Co. Ltd.
• Vaxxinova International B.V.
• Biogenesis Bagó S.A
• CZ Vaccines
• Hester Biosciences Limited
• Choong Ang Vaccine Laboratories Co. Ltd.
• Hipra Corporations
• VETVACO National Veterinary Joint Stock Company
• Kyoto Biken Laboratories Inc.
• Fatro Spa
North America was the largest region in the ruminant vaccines market in 2024